Sphingosine Kinase 2/SPHK2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-30857
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Rabbits were immunized with a synthetic peptide derived from the Sphingosine Kinase 2/SPHK2
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for Sphingosine Kinase 2/SPHK2 Antibody
Western Blot: Sphingosine Kinase 2/SPHK2 Antibody [NBP3-30857] -
Western Blot: Sphingosine Kinase 2/SPHK2 Antibody [NBP3-30857] - Western blot analysis using Sphingosine Kinase 2/SPHK2 antibody on 50 ng of recombinant Sphinogsine Kinase 2 enzyme. Antibody used at 1:200 dilution. Visualized using Pierce West Femto substrate system. Secondary used at 1:30k dilution. Exposure for 45 seconds.Applications for Sphingosine Kinase 2/SPHK2 Antibody
Application
Recommended Usage
Western Blot
: 1:50-1:200
Application Notes
.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
Phosphate buffered saline
Preservative
0.08% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: Sphingosine Kinase 2/SPHK2
Alternate Names
SK2, SPK2
Gene Symbol
SPHK2
Additional Sphingosine Kinase 2/SPHK2 Products
Product Documents for Sphingosine Kinase 2/SPHK2 Antibody
Product Specific Notices for Sphingosine Kinase 2/SPHK2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...